This revealed that the selected 36 out 37 targets (expression data for MMP3 was not available) were differentially modulated among tumor and normal tissues derived from the cholangiocarcinoma patients (Figure 4A), again consistently to what observed in the gastric cancer specimens (Table 3). This evidence concerns the gene MMP3 and gastric cancer.